What is the recommended phenylephrine dosage for an adult with hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Phenylephrine Dosage for Hypotension

For adults with hypotension, start phenylephrine at 0.5-2.0 mcg/kg/min (35-140 mcg/min in a 70-kg adult) as a continuous IV infusion, titrated to effect. 1

Dosing by Clinical Context

Severe Hypotension (SBP <70 mmHg) with Low Peripheral Resistance

  • Initial infusion rate: 0.5-2.0 mcg/kg/min (35-140 mcg/min for 70-kg adult) 1
  • Titrate at bedside to achieve target blood pressure while monitoring for side effects
  • Phenylephrine is specifically indicated for severe hypotension with low total peripheral resistance 1

Perioperative Hypotension

According to FDA labeling 2:

  • IV bolus: 50-250 mcg as needed
  • Continuous infusion: 0.5-1.4 mcg/kg/min, titrated to effect

Vasodilatory Shock (e.g., Septic Shock)

  • Continuous infusion: 0.5-6 mcg/kg/min, titrated to effect 2
  • Higher end of dosing range may be required in distributive shock states

Critical Administration Considerations

Central line administration is strongly preferred because phenylephrine and other catecholamines can cause tissue necrosis if extravasation occurs 1. If extravasation develops, immediately infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline into the affected area to prevent tissue death 1.

Titration Principles

  • No fixed infusion rates can be universally recommended due to pharmacokinetic and pharmacodynamic variations in critically ill patients 1
  • Titrate at bedside to secure intended effect while limiting side effects
  • Monitor blood pressure continuously during infusion

Drug Compatibility

  • Never mix with sodium bicarbonate or alkaline solutions in the IV line—adrenergic agents are inactivated in alkaline solutions 1
  • Be aware of concentrations delivered and compatibility with concurrent medications

Common Pitfalls and Caveats

When Phenylephrine May Not Be First Choice

While phenylephrine is effective for hypotension with low peripheral resistance, consider alternative vasopressors when:

  • Hypovolemia is present: Norepinephrine may be relatively contraindicated in hypovolemic patients 1
  • Cardiac output is already compromised: Phenylephrine's pure alpha-agonist effects can reduce cardiac output through increased afterload
  • Bradycardia is present: Consider dopamine (5-10 mcg/kg/min) for hypotension with symptomatic bradycardia 1

Context-Specific Dosing from Research

Recent studies provide more granular dosing guidance for specific populations:

  • Cesarean delivery prophylaxis: ED50 is 0.31 mcg/kg/min (95% CI: 0.24-0.36); ED90 is 0.54 mcg/kg/min (95% CI: 0.46-0.76) 3
  • Obese patients (BMI >30): Require approximately twice the dose compared to normal BMI patients 4
  • Preeclampsia: ED90 is 0.6 mcg/kg/min for preventing spinal-induced hypotension 5

Monitoring Requirements

  • Continuous blood pressure monitoring is essential 2
  • Watch for reflex bradycardia (phenylephrine's pure alpha-agonist effects can trigger baroreceptor-mediated bradycardia)
  • Monitor for signs of excessive vasoconstriction (decreased cardiac output, end-organ hypoperfusion)

Alternative Approach: Bolus Dosing

For rapid correction of acute hypotensive episodes:

  • 50-250 mcg IV bolus 2
  • Can repeat as needed while establishing continuous infusion
  • Particularly useful in perioperative settings

The guideline-based dosing range of 0.5-2.0 mcg/kg/min provides a safe starting point that can be rapidly titrated upward (to 6 mcg/kg/min in shock states) or downward based on individual patient response 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.